Announcements
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 30, 2021The event has raised more than $14 million for the nonprofit since 2007, enabling Bridge of Life to enhance kidney care globally through medical missions.
Today, DaVita announced its 15th annual Tour DaVita event raised nearly $1 million to benefit Bridge of Life, a nonprofit founded by DaVita focused on strengthening health care globally through...
-
Nov 29, 2021Research supports vaccination as an important clinical strategy to help protect vulnerable patients from virus infection.
Dialysis patients who received mRNA COVID-19 vaccines had a lower risk of COVID-19 diagnosis post-vaccination and were less likely to be hospitalized or die following breakthrough infection than...
-
Nov 4, 2021Groundbreaking research holds promise for new clinical management techniques and understanding of vaccine immune response in kidney patients
DaVita Clinical Research (DCR) will present eight research abstracts from company representatives and medical professionals during the American Society of Nephrology (ASN) Kidney Week occurring...
-
Nov 1, 2021Collaborative effort helps people take steps to better manage their diabetes and kidney health
In honor of American Diabetes Month® (ADM), the American Diabetes Association® (ADA) and DaVita are coming together to educate Americans about the connection between diabetes and kidney disease....
-
Oct 28, 2021
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2021. "The third quarter was another strong quarter for DaVita in the face of a challenging...